MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,390.00
-10.00 (-0.42%)
At close: May 13, 2025, 3:30 PM KST
-52.67%
Market Cap 5.51B
Revenue n/a
Net Income n/a
Shares Out 2.30M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 60
Average Volume 165
Open 2,200.00
Previous Close 2,400.00
Day's Range 2,040.00 - 2,390.00
52-Week Range 2,040.00 - 6,400.00
Beta 0.09
RSI 45.56
Earnings Date n/a

About MEDIZEN HUMANCARE

MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2012
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 236340
Full Company Profile

News

There is no news available yet.